ANX

(redirected from Adventrx Pharmaceuticals)
AcronymDefinition
ANXAnnex
ANXAdventrx Pharmaceuticals (San Diego, CA)
ANXAutomotive Network Exchange (AIAG)
ANXAutomatic Number Identification
ANXAutomotive Network Exchange
ANXAdvanced Network Exchange
ANXAssign NNXX Routing (US DoD)
ANXAscending Node Crossing (satellites)
ANXAnnex Records
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Previously, Bagnall was employed as the executive vice president and member of the board of directors of ADVENTRX Pharmaceuticals.
11 November 2011 - Rodman & Renshaw LLC will act as sole book-runner in a planned offering of common stock and warrants by Adventrx Pharmaceuticals Inc (AMEX:ANX), the US speciality pharmaceuticals firm said on Thursday.
US speciality pharmaceutical firm Adventrx Pharmaceuticals (AMEX:ANX) has closed its previously announced takeover of biotechnology firm SynthRx in exchange for 2.8m common shares.
Currently, Dr Goldberg is a member of the board of Navidea Biopharmaceuticals as well as a director of Alliqua, Urigen Pharmaceuticals and Adventrx Pharmaceuticals.
Biopharmaceutical company ADVENTRX Pharmaceuticals Inc (NYSE MKT:ANX) said on Thursday that it intends to develop ANX-188 in complications of arterial disease, initially as an adjunct to thrombolytics in acute limb ischemia (ALI), a complication of peripheral arterial disease, which affects an estimated 8m to 12m people in the US.
SynthRx develops a purified form of a rheologic and antithrombotic agent, poloxamer 188.Country: , USASector: PharmaceuticalsTarget: SynthRx IncBuyer: ADVENTRX Pharmaceuticals IncType: Corporate acquisitionFinancing: All-stockStatus: Closed
(YAX603) NICHOLAS JON VIRCA - ADVENTRX PHARMACEUTICALS INC (ANX).
Biopharmaceutical company ADVENTRX Pharmaceuticals Inc (NYSE MKT:ANX) said on Thursday that this quarter it plans to initiate the phase 3 clinical study of ANX-188 in sickle cell disease.
US speciality pharmaceutical firm Adventrx Pharmaceuticals (AMEX:ANX) said it has agreed to buy biotechnology firm SynthRx in exchange for 4% of its shares.
(RAX262) NICHOLAS VIRCA - ADVENTRX PHARMACEUTICALS INC (AVRX).
Biopharmaceutical company ADVENTRX Pharmaceuticals Inc (NYSE MKT:ANX) revealed on Thursday a change in its corporate name to Mast Therapeutics Inc with effect from 11 March 2013.
ADVENTRX Pharmaceuticals Inc (NYSE MKT: ANX), a biopharmaceutical company developing proprietary product candidates to treat various diseases and conditions, announced on September 7, 2012, that it has named Ted W Love, MD as its director.